DRUG SURVIVAL ON FIRST TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS: COMPARISON ACROSS ETANERCEPT, ADALIMUMAB, GOLIMUMAB AND INFLIXIMAB

被引：0
|
作者：
Garcia-Porrua, C. [1 ]
Maceiras-Pan, F. [2 ]
Fernandez-Dominguez, L. [3 ]
Mosquera-Martinez, J. A. [4 ]
Correa-Rey, B. [5 ]
Pombo-Suarez, M. [6 ]
Pinto-Tasende, J. [7 ]
机构：
[1] HU Locus Augusti, Rheumatol, Lugo, Spain
[2] CHU Vigo, Rheumatol, Vigo, Spain
[3] CHU Ourense, Rheumatol, Ourernse, Spain
[4] CHU Pontevedra, Rheumatol, Pontevedra, Spain
[5] CHU Arquitecto Marcide Naval, Rheumatol, Ferrol, Spain
[6] CHU Santiago, Rheumatol, Santiago De Compostela, Spain
[7] INIBIC XXI A Coruna, Rheumatol, La Coruna, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.4951
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0333
引用
收藏
页码：1031 / 1031
页数：1
相关论文
共 50 条
  • [41] COMPARISON OF HEALTHCARE COSTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN NORDIC SETTING
    Gokhale, S. B.
    Cassel, T.
    Mahon, R.
    Balkin, P. E.
    Singh, S.
    Bhattacharyya, S.
    Handin, J.
    Mendoza, C.
    VALUE IN HEALTH, 2016, 19 (07) : A535 - A535
  • [42] Effectiveness and drug survival of TNF inhibitors in the treatment of psoriatic arthritis: a prospective cohort study
    Heinonen, A.
    Aaltonen, K.
    Joensuu, J.
    Parmanne, P.
    Karjalainen, A.
    Varjolahti-Lehtinen, T.
    Uutela, T.
    Puurtinen-Vilkki, M.
    Arstila, L.
    Yrjo, K.
    Blom, M.
    Nordstrom, D.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2015, 44 (06) : 526 - 527
  • [43] Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs
    Atteno, Mariangela
    Peluso, Rosario
    Costa, Luisa
    Padula, Stefania
    Iervolino, Salvatore
    Caso, Francesco
    Sanduzzi, Alessandro
    Lubrano, Ennio
    Del Puente, Antonio
    Scarpa, Raffaele
    CLINICAL RHEUMATOLOGY, 2010, 29 (04) : 399 - 403
  • [44] DRUG SURVIVAL ON TNF INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN FINLAND
    Aaltonen, K. J.
    Joensuu, J.
    Pirila, L.
    Kauppi, M.
    Uutela, T.
    Varjolahti-Lehtinen, T.
    Yli-Kerttula, T.
    Isomaki, P.
    Nordstrom, D.
    Sokka, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 500 - 500
  • [45] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN EUROPE
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baynton, E.
    VALUE IN HEALTH, 2014, 17 (07) : A373 - A373
  • [46] Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs
    Mariangela Atteno
    Rosario Peluso
    Luisa Costa
    Stefania Padula
    Salvatore Iervolino
    Francesco Caso
    Alessandro Sanduzzi
    Ennio Lubrano
    Antonio Del Puente
    Raffaele Scarpa
    Clinical Rheumatology, 2010, 29 : 399 - 403
  • [47] Dosing patterns and costs of adalimumab, etanercept, and infliximab among patients with rheumatoid arthritis
    Engel-Nitz, N. M.
    Huang, X.
    Globe, D.
    Baumgartner, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 260 - 260
  • [48] A difference in effectiveness between infliximab, etanercept and adalimumab in patients with rheumatoid arthritis.
    Kievit, Wietske
    Fransen, Jaap
    Kuper, Ina H.
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    De Rooij, Dirk jan R. A. M.
    de Gendt, Carla M.
    Ronday, Karel H.
    Brus, Herman L. M.
    van Ooijen, Piet C. M.
    van Riel, Piet C. L. M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S309 - S310
  • [49] Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab
    Ruwaard, J.
    l'Ami, M. J.
    Marsman, A. F.
    Kneepkens, E. L.
    van Denderen, J. C.
    van der Horst-Bruinsma, I. E.
    Nurmohamed, M. T.
    Wolbink, G.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (02) : 122 - 126
  • [50] Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival
    Flouri, Irini
    Markatseli, Theodora E.
    Voulgari, Paraskevi V.
    Boki, Kyriaki A.
    Papadopoulos, Ioannis
    Settas, Loukas
    Zisopoulos, Dimitrios
    Skopouli, Fotini N.
    Iliopoulos, Alexios
    Bertsias, George K.
    Geborek, Pierre
    Drosos, Alexandros A.
    Boumpas, Dimitrios T.
    Sidiropoulos, Prodromos
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2014, 43 (04) : 447 - 457
12345